Related Experiment Video
Updated: Aug 29, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Cerebrovascular radiological features of COVID-19 positive patients
1Department of Radiology, Faculty of Medicine, Malatya Turgut Ozal University, Malatya, Turkey. petikbulent@gmail.com.
Insights
COVID-19 patients with neurological symptoms showed a significant incidence of acute cerebrovascular diseases, including stroke and hemorrhage. Cranial imaging is crucial for early detection and management of these life-threatening conditions in infected individuals.
Area of Science:
- Neurology
- Radiology
- Infectious Diseases
Background:
- The emergence of coronavirus disease 2019 (COVID-19) has been associated with various neurological complications.
- Acute cerebrovascular diseases, such as stroke and intracranial hemorrhage, pose significant risks to patient health and survival.
Purpose of the Study:
- To investigate the occurrence of acute cerebrovascular diseases in patients with COVID-19 presenting with neurological signs.
- To analyze cranial radiologic findings in COVID-19 patients with suspected cerebrovascular events.
Main Methods:
- A retrospective study included 925 patients admitted between March 2020 and May 2021 with confirmed COVID-19 and neurological symptoms.
- Patients underwent Multidetector Computed Tomography (MDCT) and/or Magnetic Resonance Imaging (MRI), including diffusion MRI.
- Data on cerebrovascular events, demographics, and imaging results were analyzed.
Main Results:
- Cerebrovascular diseases were detected in 13.8% of the 925 COVID-19 patients.
- Stroke (ischemic or hemorrhagic) was found in 9.9%, intraparenchymal hemorrhage in 4%, subarachnoid hemorrhage in 1.1%, and subdural hemorrhage in 0.43%.
- Stroke incidence varied significantly with age, while hemorrhage types did not show significant gender-based differences.
Conclusions:
- Cerebrovascular diseases are a significant concern in COVID-19 patients with neurological symptoms.
- Prompt cranial radiologic examinations are essential for diagnosing and managing these potentially fatal conditions.
- Awareness of these risks is critical for clinicians managing COVID-19 patients.
Objective:
To investigate acute cerebrovascular diseases (stroke and intracranial hemorrhage) by cranial radiologic examinations of patients infected with coronavirus disease 2019 (COVID-19) and with neurological signs.
Patients And Methods:
Between March 2020 and May 2021, patients who were admitted to the Emergency Department and had a positive reverse transcription-polymerase chain reaction (RT-PCR) test and underwent Multidetector Computed Tomography (MDCT) and/or Magnetic Resonance Images (MRI), and/or diffusion MRI due to neurological findings were included in the study.
Results:
The study reviewed a total of 925 patients, including 404 (43.67%) female and 521 (56.32%) male patients. The distribution of imaging methods was as follows: 805 (71%) patients had cranial MDCT, 71 (6.35%) patients had MRI, and 241 (21.57%) patients had diffusion MRI. Of the total 925 patients, 128 (13.8%) patients were detected with cerebrovascular diseases, 92 (9.9%) patients were detected with ischemic or hemorrhagic stroke, 37 (4%) patients were detected with intraparenchymal hemorrhage, 10 (1.1%) patients were detected with subarachnoid hemorrhage, and four (0.43%) patients were detected with subdural hemorrhage. There was no statistically significant difference in the incidence of subdural, subarachnoid, parenchymal hemorrhage, and stroke in terms of gender. While there was a significant difference in stroke according to age, there was no statistically significant difference in subdural, subarachnoid, and parenchymal hemorrhagic. Three (0.32%) patients were diagnosed with acute disseminated encephalomyelitis (ADEM)'s-like demyelinating lesions.
Conclusions:
Cerebrovascular diseases, which may cause severe disability and even threaten the patient's life, should be kept in mind, especially in COVID-19 patients who present with neurological symptoms.
More Related Videos
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Imaging Studies VII: Vascular Imaging
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System IV: CMRI

